Arthritis Industry, March 2015 Market Reports from Top Publishers

You might be interested in: Drug, Clinical Trial, Diagnostics, Biosimilar, Pharmaceutical, Orthopedic Prosthesis, Antibody, Biosimilars, Cell Therapy, Minimally Invasive Surgery, Monoclonal Antibody, Pain Management Therapeutics, Sports Medicine.


 
1-10 of 95 reports for Arthritis

Purchase Reports From Reputable Market Research Publishers

Global Osteoarthritis Market 2015-2019

Global Osteoarthritis Market 2015-2019

  • $ 2 500
  • Industry report
  • March 2015
  • by Infiniti Research Limited

About OA OA is a condition in which the cartilage, a material that cushions the joints, breaks down. This leads to stiffness, inflammation, pain, and loss of joint movement. The exact etiology of OA is ...

Sarcoidosis - Pipeline Review, H1 2015

Sarcoidosis - Pipeline Review, H1 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Global Markets Direct

Sarcoidosis - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Sarcoidosis - Pipeline Review, H1 2015’, provides an overview of the Sarcoidosis’s therapeutic pipeline. This report provides ...

Systemic Juvenile Idiopathic Arthritis (SJIA)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Systemic Juvenile Idiopathic Arthritis (SJIA)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight’s, “Systemic Juvenile Idiopathic Arthritis (SJIA)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline ...

Systemic Juvenile Rheumatoid Arthritis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Systemic Juvenile Rheumatoid Arthritis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight’s, “Systemic Juvenile Rheumatoid Arthritis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs ...

Gouty Arthritis (Gout)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Gouty Arthritis (Gout)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight’s, “Gouty Arthritis (Gout)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed ...

Arthritis Pain-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Arthritis Pain-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight’s, “Arthritis Pain-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across ...

Juvenile Arthritis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Juvenile Arthritis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight’s, “Juvenile Arthritis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs ...

Juvenile Rheumatoid Arthritis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Juvenile Rheumatoid Arthritis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight’s, “Juvenile Rheumatoid Arthritis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed ...

Osteoarthritis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Osteoarthritis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight’s, “Osteoarthritis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across ...

Psoriatic Arthritis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Psoriatic Arthritis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight’s, “Psoriatic Arthritis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs ...

About 7 000 reports for Arthritis

Download Unlimited Documents from Trusted Public Sources

Pathology Description in Australia

  • January 2013
    110 pages
  • Arthritis  

    Musculoskeletal...  

  • Australia  

View report >

Pathology Description

February 2015

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.